Health Canada Provides Positive Feedback on Tetra Bio-Pharma’s Application for ARDS-003 to be Studied in COVID-19 Patients at Risk of Developing Acute Respiratory Distress Syndrome

Go back to Health Canada Provides Positive Feedback on Tetra Bio-Pharma’s Application for ARDS-003 to be Studied in COVID-19 Patients at Risk of Developing Acute Respiratory Distress Syndrome
(AMEX: TBPMF) Delayed: 0.31 --0 (-0%)
Previous Close $0.31    52 Week High
Open $0.31    52 Week Low
Day High $0.31    P/E N/A 
Day Low $0.31    EPS
Volume 1,000